The US FDA has granted approval for Daiichi Sankyo’s Vanflyta to treat adults wi...
The FDA grants SN Bioscience’s nano-therapy SNB-101 an orphan drug designation f...
Other forms of immunotherapy have progressed rapidly in recent years, but oncoly...
To reduce cash burn, the company has sold off its Asia Pacific operations, excep...
Janssen has plans to discontinue the CD388 influenza programme as part of pipeli...
While artificial intelligence (AI) in medical devices has regulatory boundaries,...
In the global pharmaceutical industry, there were 7 private equity deals announc...
A new review finds that private equity ownership generally means higher costs fo...
Sen. Bernie Sanders wants to do away with drug patents and other IP protections ...
What can Homer teach us about biotech? Has Big Science gotten too big? And what'...
In the latest edition of STAT's Health Tech newsletter: priming doctors for GPT-...
Marc Tessier-Lavigne's abrupt departure as Stanford's president after a research...
“It’s hard to know exactly what the impact will be, but this stands to just make...
Health care companies trying to merge can expect tougher policing from the top f...
It’s another setback for Vir in its efforts to build off its success during the ...
The FTC on Thursday plans to issue a statement “cautioning against reliance” on ...
